"Fibric Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that either share the structure of fibric acid in their molecular arrangement or are considered variants of the fibric acid structure.
| Descriptor ID |
D058607
|
| MeSH Number(s) |
D02.241.081.114.968.500 D02.355.726.305 D02.455.426.559.389.657.654.305
|
| Concept/Terms |
Fibric Acids- Fibric Acids
- Methyl-2-Phenoxypropanoic Acid Derivatives
- Methyl 2 Phenoxypropanoic Acid Derivatives
- Fibric Acid Derivatives
- Acid Derivatives, Fibric
- 2-Phenoxy Isobutyric Acids
- 2 Phenoxy Isobutyric Acids
- Isobutyric Acids, 2-Phenoxy
- 2-Phenoxy-2-Methylpropionic Acid Derivatives
- 2 Phenoxy 2 Methylpropionic Acid Derivatives
|
Below are MeSH descriptors whose meaning is more general than "Fibric Acids".
Below are MeSH descriptors whose meaning is more specific than "Fibric Acids".
This graph shows the total number of publications written about "Fibric Acids" by people in this website by year, and whether "Fibric Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 1 | 4 |
| 2018 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Fibric Acids" by people in Profiles.
-
Lipid management in patients with chronic kidney disease. Nat Rev Nephrol. 2018 12; 14(12):727-749.
-
Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials. Ann Med. 2018 09; 50(6):485-493.
-
Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacol Res. 2018 06; 132:232-241.
-
The Microvascular and Macrovascular Benefits of Fibrates in Diabetes and the Metabolic Syndrome: A review. Mo Med. 2017 Nov-Dec; 114(6):464-471.
-
Lipid management in India: a nationwide, cross-sectional physician survey. Lipids Health Dis. 2017 Jul 03; 16(1):130.
-
Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials. BMC Med. 2017 Feb 03; 15(1):22.
-
Severe decrease in high-density lipoprotein cholesterol with the combination of fibrates and ezetimibe: A case series. J Clin Lipidol. 2017 Jan - Feb; 11(1):289-293.
-
Fibrates and cardiorenal outcomes. J Am Coll Cardiol. 2012 Nov 13; 60(20):2072-3.